What is the recommended treatment for an elderly patient with confirmed COVID-19, including the use of Paxlovid (nirmatrelvir/ritonavir) and potential adjunctive therapy with prednisone?

Paxlovid Prescription for Elderly COVID-19 Patient

Direct Recommendation

Yes, prescribe Paxlovid (nirmatrelvir/ritonavir) for this elderly patient with confirmed COVID-19, but you must perform a mandatory medication review using a drug interaction checker before prescribing, and prednisone (or any systemic corticosteroid) should NOT be prescribed unless the patient requires supplemental oxygen. 1, 2

---

Paxlovid Prescription Details

Eligibility Confirmation Required

• Confirm COVID-19 diagnosis (positive test) 1
• Verify symptom onset is within 5 days (though evidence suggests benefit up to 10 days if viral load remains high) 1, 3
• Elderly patients (≥65 years) automatically qualify as high-risk 1
• Ensure patient does NOT require supplemental oxygen (Paxlovid is for mild-to-moderate disease only) 4

Critical Pre-Prescribing Step: Drug Interaction Review

You MUST complete a comprehensive medication review using a drug interaction checker before prescribing Paxlovid. 1 Ritonavir is a potent CYP3A4 inhibitor that can cause potentially life-threatening drug interactions. 4, 5 This is particularly critical in elderly patients who typically take multiple medications. 6, 2

Contraindicated medications include: 4

• Drugs highly dependent on CYP3A4 for clearance where elevated concentrations cause serious/life-threatening reactions
• Potent CYP3A inducers that would reduce nirmatrelvir/ritonavir effectiveness

Dosing for Elderly Patients

Standard dose (if eGFR ≥60 mL/min): 4

• Nirmatrelvir 300 mg (two 150 mg tablets) + ritonavir 100 mg (one 100 mg tablet)
• Take all 3 tablets together twice daily for 5 days
• Can be taken with or without food

Dose reduction for moderate renal impairment (eGFR 30-59 mL/min): 4

• Nirmatrelvir 150 mg (one 150 mg tablet) + ritonavir 100 mg (one 100 mg tablet)
• Twice daily for 5 days

Dose reduction for severe renal impairment (eGFR <30 mL/min): 4

• Day 1: Nirmatrelvir 300 mg + ritonavir 100 mg once
• Days 2-5: Nirmatrelvir 150 mg + ritonavir 100 mg once daily

Note: While older guidelines suggested reducing all COVID-19 medications to 1/2 dose for patients over 80 years, 2, 7 the current FDA-approved dosing for Paxlovid is based on renal function, not age alone. 4

Expected Benefits in Elderly Patients

• 39% relative risk reduction in hospitalization 8
• 61% relative risk reduction in death 8
• Particularly beneficial for patients ≥65 years who show greater absolute risk reduction 8
• Reduces viral load and shortens disease course 3, 9

---

Prednisone Recommendation: DO NOT PRESCRIBE (Unless Oxygen Required)

Systemic corticosteroids like prednisone should NOT be used in mild-to-moderate COVID-19 without oxygen requirement. 1, 2, 7 This is a critical error that worsens outcomes.

Why Corticosteroids Are Contraindicated in Mild Disease

• Corticosteroids show no benefit in mild-moderate disease and may prolong viral clearance 2
• They increase 28-day mortality when used before oxygen requirement develops 2
• Using corticosteroids too early in the viral phase delays viral clearance and worsens outcomes 2, 7

When Corticosteroids ARE Indicated

Only prescribe dexamethasone 6 mg daily for 10 days if: 2, 7

• Patient requires supplemental oxygen therapy
• This reduces all-cause mortality by 3% and decreases mechanical ventilation requirements in severe disease 2, 7

---

Additional Management for Elderly COVID-19 Patients

Supportive Care Measures

• Ensure adequate nutrition and fluid intake (limit to <2 liters daily to prevent fluid overload) 2, 7
• Use paracetamol (preferred over NSAIDs) for fever only while symptoms persist 2
• Teach controlled breathing techniques including pursed-lip breathing 2
• Position patient sitting upright and leaning forward with arms bracing to improve ventilation 2

Critical Monitoring Requirements

• Monitor for secondary bacterial infections aggressively - elderly patients have significantly higher neutrophil ratios indicating greater infection susceptibility 6, 2, 7
• Monitor D-dimer and coagulation parameters closely - elderly COVID-19 patients show significantly elevated D-dimer indicating higher risk of disseminated intravascular coagulation 6, 2, 7
• Monitor hepatic function if baseline liver abnormalities present 1
• Implement anticoagulation therapy given increased thromboembolic risk 2, 7

Polypharmacy Management

• Review ALL current prescriptions to minimize polypharmacy and prevent drug-drug interactions 6, 2, 7
• Use medications with lowest interaction potential at minimum effective doses for shortest duration 6, 2
• Engage multidisciplinary team (pharmacists, nurses, physiotherapists, mental health providers) in collaborative decision-making 6, 2, 7

---

Common Pitfalls to Avoid

1. Prescribing Paxlovid without checking drug interactions - This can cause life-threatening complications 1, 4, 5
2. Using corticosteroids in mild disease - This worsens outcomes and delays viral clearance 2, 7
3. Delaying Paxlovid initiation - Start as soon as possible within 5 days of symptom onset 1, 4
4. Ignoring renal function - Dose must be adjusted for renal impairment 4
5. Failing to monitor for complications - Elderly patients require aggressive surveillance for secondary infections and coagulopathy 6, 2, 7